molecular formula C21H29FO5 B194907 Fludrocortisone CAS No. 127-31-1

Fludrocortisone

Cat. No.: B194907
CAS No.: 127-31-1
M. Wt: 380.4 g/mol
InChI Key: AAXVEMMRQDVLJB-BULBTXNYSA-N
Attention: For research use only. Not for human or veterinary use.
In Stock
  • Click on QUICK INQUIRY to receive a quote from our team of experts.
  • With the quality product at a COMPETITIVE price, you can focus more on your research.

Description

Historical Perspectives in Endocrine Research

The journey of fludrocortisone began in the early 1950s, a period of significant advancements in steroid chemistry and endocrinology. Following the introduction of cortisone in 1948 and hydrocortisone in 1951, researchers sought to create synthetic analogues with more potent and specific activities. tandfonline.com this compound, also known as 9α-fluorocortisol, was first described in the scientific literature in 1953 and was introduced for medical use as its acetate ester in 1954. tandfonline.comwikipedia.org This marked a significant milestone as it was the first synthetic corticosteroid to be marketed and, notably, the first fluorine-containing pharmaceutical drug. tandfonline.comwikipedia.orgnih.gov

The key innovation in the synthesis of this compound was the introduction of a fluorine atom at the 9α position of the steroid nucleus of hydrocortisone. nih.gov This structural modification was the result of the pioneering work by researchers including Josef Fried and Emily F. Sabo. tandfonline.comnih.gov Their research, published in 1954, demonstrated that this halogenation dramatically enhanced the biological activity of the parent compound. mdpi.com Specifically, the 9α-fluoro derivative exhibited a substantial increase in both glucocorticoid and, most notably, mineralocorticoid potency. nih.gov

Initially, the primary application of this compound was in the management of primary adrenal insufficiency, known as Addison's disease. wikipedia.orgaafp.orgwebmd.comaddisonsdisease.org.uk In this condition, the adrenal glands fail to produce adequate amounts of endogenous corticosteroids, particularly cortisol and aldosterone. aafp.orgmayoclinic.org this compound's potent mineralocorticoid effects made it an effective replacement for aldosterone, helping to regulate sodium and water balance in the body. webmd.comaddisonsdisease.org.uk Early clinical investigations focused on its efficacy in correcting the electrolyte imbalances and hypotension characteristic of Addison's disease. aafp.org

Evolution of Research Paradigms on this compound

The research landscape for this compound has evolved considerably since its initial use as an aldosterone replacement. While its role in treating Addison's disease and other forms of adrenal insufficiency, such as salt-losing congenital adrenal hyperplasia, remains fundamental, the scientific inquiry has expanded to explore its utility in other conditions characterized by dysregulation of blood pressure and volume. wikipedia.orgahajournals.orgnih.gov

A significant shift in research occurred with the investigation of this compound for the treatment of orthostatic hypotension, a condition marked by a significant drop in blood pressure upon standing. wikipedia.orgclinicaltrials.eu This line of research was a logical extension of its known mechanism of action: promoting sodium and water retention, thereby expanding plasma volume. nih.govderangedphysiology.com Numerous clinical studies have since evaluated its effectiveness in managing the symptoms of orthostatic hypotension, particularly in patients with autonomic dysfunction. clinicaltrials.eunih.govnih.govnice.org.uk

Further evolution in the research paradigm led to the exploration of this compound for other disorders of the autonomic nervous system, including Postural Orthostatic Tachycardia Syndrome (POTS). wikipedia.orgnih.goveurospe.org In POTS, an abnormal increase in heart rate occurs upon standing, often accompanied by symptoms of orthostatic intolerance. Research has investigated this compound's potential to alleviate these symptoms by increasing blood volume. nih.goveurospe.org

The understanding of this compound's mechanism of action has also deepened over time. Initially, its effects were primarily attributed to its genomic actions on the mineralocorticoid receptors in the distal tubules of the kidneys, leading to increased sodium reabsorption and potassium excretion. nih.govdrugbank.com However, more recent research has uncovered evidence of non-genomic effects of mineralocorticoids, which are rapid and not dependent on gene transcription. frontiersin.orgnih.govnih.gov These findings have opened new avenues for understanding the full spectrum of this compound's physiological effects.

Another significant development in this compound research has been its use as a diagnostic tool. The this compound suppression test was developed to help diagnose primary aldosteronism (Conn's syndrome), a condition of excessive aldosterone production. wikipedia.orgahajournals.orgnih.govresearchgate.net In individuals with normal adrenal function, the administration of this compound suppresses endogenous aldosterone production; this suppression is absent in patients with primary aldosteronism. wikipedia.orgahajournals.org Studies have evaluated the diagnostic accuracy of this test, comparing it with other confirmatory tests for primary aldosteronism. ahajournals.orgnih.govresearchgate.netresearchgate.netsfhta.eu

Detailed Research Findings

Comparative Potency of Corticosteroids

The introduction of a fluorine atom at the 9α position of the cortisol molecule significantly alters its biological activity. The table below provides a comparison of the relative potencies of this compound and other common corticosteroids.

CorticosteroidRelative Anti-inflammatory (Glucocorticoid) PotencyRelative Mineralocorticoid Potency
Hydrocortisone11
Cortisone0.80.8
Prednisolone40.8
Methylprednisolone50.5
Dexamethasone25-300
This compound 10 125-200

This table compiles data from multiple sources to show the relative potencies of various corticosteroids compared to hydrocortisone. drugbank.com

Clinical Research Findings in Orthostatic Hypotension

Several clinical studies have investigated the efficacy of this compound in managing orthostatic hypotension. The findings from some of these studies are summarized below.

Study (Year)ConditionNumber of ParticipantsKey Findings
Campbell et al. (1975)Orthostatic hypotension in diabetic neuropathy6This compound significantly increased tilted systolic blood pressure (154 mmHg vs. 110 mmHg with placebo, p<0.005) and reduced the drop in systolic blood pressure upon tilting (-26 mmHg vs. -39 mmHg with placebo). nih.govnice.org.uk
Schoffer et al. (2007)Orthostatic hypotension in Parkinson's disease17This compound significantly improved the orthostatic domain score of the Composite Autonomic Symptom Scale compared to non-pharmacological treatment alone. nice.org.uk
Finke & Sagemüller (1975)Orthostatic hypotension30 (treatment group)The this compound group showed a higher systolic ophthalmic blood pressure on standing and a smaller fall in pulse volume compared to the placebo group. nih.gov

Compound Names

Properties

IUPAC Name

(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI

InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI Key

AAXVEMMRQDVLJB-BULBTXNYSA-N
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Canonical SMILES

CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Isomeric SMILES

C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Molecular Formula

C21H29FO5
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

DSSTOX Substance ID

DTXSID7023061
Record name Fludrocortisone
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID7023061
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.

Molecular Weight

380.4 g/mol
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Physical Description

Solid
Record name Fludrocortisone
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014825
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Solubility

In water, 140 mg/L at 25 °C, 2.24e-01 g/L
Record name FLUDROCORTISONE
Source Hazardous Substances Data Bank (HSDB)
URL https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3332
Description The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.
Record name Fludrocortisone
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014825
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Color/Form

Crystals

CAS No.

127-31-1
Record name Fludrocortisone
Source CAS Common Chemistry
URL https://commonchemistry.cas.org/detail?cas_rn=127-31-1
Description CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.
Explanation The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.
Record name Fludrocortisone [INN:BAN]
Source ChemIDplus
URL https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000127311
Description ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.
Record name Fludrocortisone
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00687
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name fludrocortisone
Source DTP/NCI
URL https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=11318
Description The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.
Explanation Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.
Record name Fludrocortisone
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID7023061
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.
Record name Fludrocortisone
Source European Chemicals Agency (ECHA)
URL https://echa.europa.eu/substance-information/-/substanceinfo/100.004.395
Description The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.
Explanation Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
Record name FLUDROCORTISONE
Source FDA Global Substance Registration System (GSRS)
URL https://gsrs.ncats.nih.gov/ginas/app/beta/substances/U0476M545B
Description The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.
Explanation Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.
Record name FLUDROCORTISONE
Source Hazardous Substances Data Bank (HSDB)
URL https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3332
Description The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.
Record name Fludrocortisone
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014825
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Molecular and Cellular Mechanisms of Fludrocortisone Action

Mineralocorticoid Receptor Agonism and Downstream Signaling

Fludrocortisone functions as a powerful agonist for the mineralocorticoid receptor (MR). medkoo.comoup.com Its chemical structure, which includes a fluorine atom at the 9-alpha position, significantly enhances its mineralocorticoid potency, making it hundreds of times more potent than endogenous cortisol in this regard. drugbank.comsukl.sk While it also binds to glucocorticoid receptors (GR), its affinity for the MR is substantially higher, leading to its predominant use for mineralocorticoid replacement. oup.comguidetopharmacology.org

The downstream signaling cascade initiated by this compound binding to the MR involves a series of steps that ultimately alter gene expression and protein synthesis, leading to physiological changes in ion transport. drugbank.commedicaldialogues.in

Due to its high lipid solubility, this compound readily crosses the cell membrane and binds to MRs located in the cytoplasm. nih.gov These receptors, in their inactive state, are part of a complex with chaperone proteins. nih.gov Upon binding with this compound, the receptor undergoes a conformational change, sheds the chaperone proteins, and exposes a nuclear localization signal. nih.govcancer.gov This prompts the translocation of the this compound-MR complex into the nucleus. nih.govcancer.gov

Inside the nucleus, the activated receptor complex acts as a ligand-activated transcription factor. nih.gov It typically forms homodimers which then bind to specific DNA sequences known as hormone response elements (HREs) located in the promoter regions of target genes. nih.govnih.gov This binding event is a critical step in initiating the transcription of these genes. nih.gov

Key Research Findings on Receptor Dynamics:

Studies using single-molecule microscopy have shown that the specific ligand bound to a steroid receptor, such as this compound, influences the receptor's DNA-binding dynamics, including the duration of binding events. plos.org

The 9-fluoro group, a key feature of this compound's structure, is known to form a strong hydrogen bond with phenylalanine at position 623 of the glucocorticoid receptor's ligand-binding pocket, suggesting this interaction is crucial for its potent effects. plos.org

The binding of the this compound-MR complex to HREs modulates the transcription of a specific set of genes, leading to changes in the synthesis of proteins that regulate ion transport. drugbank.comsukl.sknih.gov This genomic mechanism is responsible for the primary physiological effects of this compound.

A primary target of this compound action is the gene encoding the epithelial sodium channel (ENaC). drugbank.commedicaldialogues.incoggle.it this compound upregulates the expression of ENaC subunits, leading to an increased density of these channels on the apical membrane of epithelial cells, particularly in the distal tubules and collecting ducts of the kidney. drugbank.commedicaldialogues.incoggle.it This increased expression enhances the reabsorption of sodium ions from the tubular fluid back into the bloodstream. drugbank.com

Research Highlight: ENaC Regulation A study in rats demonstrated that treatment with this compound significantly increased the protein expression of the ENaC-α subunit in the urinary bladder epithelium. nih.gov This upregulation was associated with changes in bladder function, which were normalized by an ENaC inhibitor, highlighting the direct link between this compound-induced ENaC expression and physiological outcomes. nih.gov

In concert with its effects on ENaC, this compound also increases the expression and density of the Na+-K+-ATPase pump on the basolateral membrane of renal tubule cells. drugbank.commedicaldialogues.incoggle.it This enzyme actively transports sodium out of the cell into the interstitium and potassium into the cell, maintaining the low intracellular sodium concentration that drives sodium reabsorption through the apical ENaC. nih.gov The coordinated upregulation of both ENaC and Na+-K+-ATPase is crucial for efficient sodium retention. drugbank.com

This compound influences the expression of the Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) gene. umsu.ac.ir SGK1 is a kinase that plays a significant role in regulating ENaC activity. umsu.ac.irgenome.jp Increased SGK1 expression, stimulated by mineralocorticoids, leads to the phosphorylation of proteins that prevent the degradation of ENaC, thereby increasing the number of active channels at the cell surface. genome.jp However, in some contexts, such as the endometrium during the implantation window, this compound has been observed to slightly downregulate SGK1 expression. umsu.ac.irumsu.ac.ir Glucocorticoid deficiency has been shown to decrease SGK1, which can affect cardiac repolarization by altering the expression of the hERG gene. endocrine-abstracts.org

GeneEffect of this compoundPrimary Function
ENaC UpregulationFacilitates sodium reabsorption from the renal filtrate. drugbank.commedicaldialogues.in
Na+-K+-ATPase UpregulationMaintains the sodium gradient for reabsorption. drugbank.commedicaldialogues.in
SGK1 Modulation (often upregulation)Regulates ENaC activity and stability. umsu.ac.irgenome.jp

Beyond its genomic effects, this compound can also exert more rapid, non-genomic actions. drugbank.comcoggle.it One such effect is the modulation of the Na+-H+ exchanger, located on the apical membrane of renal tubule cells. medicaldialogues.incoggle.it Studies have shown that mineralocorticoids can rapidly activate this exchanger, contributing to increased sodium influx. oup.comnih.gov This activation appears to be mediated by protein kinase C (PKC). oup.comnih.gov This rapid pathway complements the slower, transcription-dependent mechanisms of sodium reabsorption. oup.com

Transcriptional Regulation of Target Genes

Na+-K+-ATPase Density

Glucocorticoid Receptor Interactions and Differential Potency

This compound interacts with both mineralocorticoid receptors (MR) and glucocorticoid receptors (GR), which are members of the steroid receptor superfamily of hormone-dependent transcription factors. nih.gov These receptors are primarily located in the cytoplasm and translocate to the nucleus after binding to their ligand. nih.gov While this compound binds to both receptor types, it displays a significantly higher potency for the MR. drugbank.comwikipedia.org

Compared to the endogenous glucocorticoid cortisol, this compound has approximately 10 times the glucocorticoid potency. wikipedia.orglitfl.com However, its mineralocorticoid potency is vastly greater, estimated to be 125 to 800 times that of cortisol. wikipedia.orgtokyovets.commsdvetmanual.com This differential potency is a key characteristic of this compound, making it a powerful mineralocorticoid agent with some, but comparatively weaker, glucocorticoid effects. wikipedia.orgtokyovets.com The high mineralocorticoid activity is attributed to the presence of a fluorine atom at the 9-alpha position of the steroid structure. nih.gov

The affinity of receptors for corticosteroids plays a crucial role in their physiological effects. The MR has a 10-fold higher affinity for cortisol compared to the GR. frontiersin.orgoup.com This means that at basal levels of corticosteroids, the MR is predominantly occupied. frontiersin.org As corticosteroid levels rise, such as during stress, the lower-affinity GR becomes progressively saturated. frontiersin.org this compound's potent agonism at the MR means it can elicit strong mineralocorticoid responses. researchgate.net

Table 1: Relative Potencies of this compound

SteroidRelative Glucocorticoid Potency (compared to Cortisol)Relative Mineralocorticoid Potency (compared to Cortisol)
Cortisol11
This compound10 wikipedia.orglitfl.com125-800 wikipedia.orgtokyovets.commsdvetmanual.com

Genomic and Non-Genomic Signaling Pathways

Corticosteroids like this compound exert their effects through both genomic and non-genomic signaling pathways. derangedphysiology.comnih.gov The classical genomic pathway involves the binding of the steroid to its cytoplasmic receptor, translocation of the receptor-ligand complex to the nucleus, and subsequent regulation of gene transcription. nih.govresearchgate.net This process typically occurs over hours and leads to the synthesis of new proteins that mediate the physiological response. nih.govderangedphysiology.com

In addition to the slower genomic effects, this compound can also trigger rapid, non-genomic responses that occur within minutes. nih.govderangedphysiology.com These effects are too quick to be explained by changes in gene transcription and protein synthesis. oup.com Rapid non-genomic actions are thought to be mediated by membrane-bound receptors or by direct interactions with cellular membranes and intracellular second messenger systems. derangedphysiology.comderangedphysiology.com

Research suggests the existence of low-affinity membrane-associated receptor variants for both MR and GR that are activated by rising corticosteroid levels. frontiersin.org These membrane receptors can initiate rapid signaling cascades. frontiersin.org Some non-genomic effects of mineralocorticoids, mimicked by this compound, have been shown to be not blocked by the classical MR antagonist spironolactone, suggesting a distinct mechanism of action. nih.gov

This compound has been demonstrated to activate several key intracellular signaling cascades, contributing to its diverse cellular effects. These pathways are crucial for processes like cell survival, proliferation, and metabolism. frontiersin.orgnih.gov

Studies in adult rat hippocampal progenitor cells have shown that this compound can activate the cyclic AMP (cAMP)/protein kinase A (PKA) signaling pathway, the phosphoinositide 3-kinase (PI3K)/Akt pathway, and the mammalian target of rapamycin (mTOR) pathway. frontiersin.orgnih.gov The PI3K/Akt/mTOR pathway is a central regulator of cell growth and proliferation. wikipedia.orgnih.govmdpi.com

This compound has been shown to induce a rapid increase in cAMP levels and promote the phosphorylation of the cAMP response element-binding protein (CREB). frontiersin.orgnih.gov In adult hippocampal progenitor cells, this compound-induced CREB phosphorylation peaked at 15 minutes. nih.govresearchgate.net CREB is a transcription factor that, when phosphorylated, can regulate the expression of genes involved in neuronal survival and plasticity. nih.gov The activation of CREB by this compound suggests a role for non-genomic signaling in its effects. nih.gov The PI3K/Akt pathway can also contribute to CREB phosphorylation, indicating potential crosstalk between these signaling cascades. nih.govnih.gov

This compound has been found to regulate glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase involved in a wide range of cellular processes, including cell cycle regulation and apoptosis. frontiersin.orgfrontiersin.org GSK-3β is typically active in resting cells and is inhibited by upstream signaling pathways. mdpi.com In adult hippocampal progenitors, this compound treatment led to a strong and sustained increase in the phosphorylation of GSK-3β at Serine9, which is an inhibitory phosphorylation. frontiersin.org This inactivation of GSK-3β is a downstream effect of Akt activation and is associated with pro-survival signals. frontiersin.org

The mTOR pathway is a critical regulator of cell growth, proliferation, and survival. nih.govresearchgate.net this compound has been shown to modulate the mTOR pathway. frontiersin.orgnih.gov In studies on uterine receptivity in mice, this compound was found to affect this process through the activation of the ERK1/2-mTOR pathway. nih.govnih.gov In adult hippocampal progenitor cells, this compound increased the phosphorylation of p70S6K, a downstream target of the mTOR complex 1 (mTORC1), indicating activation of this pathway. frontiersin.org The mTOR pathway has been linked to synaptic plasticity and neurogenesis. frontiersin.org

Activation of Intracellular Signaling Cascades (e.g., cAMP/PKA, PI3K/Akt, mTOR)

Glycogen Synthase Kinase-3β (GSK-3β) Regulation

Tissue-Specific Mechanisms of Action

The physiological and pharmacological effects of this compound are not uniform throughout the body. Instead, they are highly dependent on the specific tissue, the local expression of steroid receptors, and the presence of regulatory enzymes. This results in distinct molecular and cellular outcomes in different organ systems, most notably the kidneys, the cardiovascular system, and the central nervous system.

Kidneys

In the kidneys, this compound primarily exerts its effects by mimicking the action of the endogenous mineralocorticoid, aldosterone. patsnap.com Its mechanism is centered on the regulation of electrolyte and water balance in the distal nephron.

Receptor Binding and Gene Transcription: this compound binds with high affinity to mineralocorticoid receptors (MR) located in the cytoplasm of epithelial cells in the distal tubules and collecting ducts. patsnap.comnih.gov This binding event triggers the translocation of the receptor-ligand complex into the nucleus, where it modulates the transcription of specific genes. nih.gov

Regulation of Ion Channels and Pumps: The primary outcome of this gene regulation is an increased expression and activity of key transport proteins. drugbank.com

It increases the density of epithelial sodium channels (ENaC) on the apical membrane of the tubular cells. derangedphysiology.com

It enhances the activity of the Na+/K+-ATPase pump on the basolateral membrane. drugbank.com

The coordinated action of these proteins leads to increased reabsorption of sodium and water from the tubular fluid back into the bloodstream and an increased secretion of potassium and hydrogen ions into the urine. patsnap.comnih.govdrugbank.com

Enzymatic Specificity: The selectivity of this compound's action in the kidney is critically dependent on the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). mdpi.comfrontiersin.org This enzyme is highly expressed in renal epithelial tissues and converts cortisol, which circulates at much higher concentrations than aldosterone, into its inactive metabolite, cortisone. mdpi.comfrontiersin.org This enzymatic barrier prevents cortisol from overwhelming the MR, thereby allowing aldosterone and potent synthetic agonists like this compound to exert their effects. frontiersin.org

Table 1: Effects of this compound on Renal Ion Transport

Target ProteinLocation in Renal CellEffect of this compoundPhysiological Consequence
Epithelial Sodium Channel (ENaC)Apical MembraneIncreased expression and activityEnhanced sodium reabsorption
Na+/K+-ATPaseBasolateral MembraneIncreased expression and activityDrives sodium reabsorption and potassium secretion
Renal Outer Medullary Potassium Channel (ROMK)Apical MembraneIncreased activity (indirectly)Enhanced potassium secretion

Cardiovascular System

The actions of this compound on the cardiovascular system are multifaceted, involving both indirect effects secondary to its renal actions and direct effects on cardiovascular tissues.

Volume Expansion and Blood Pressure: By promoting renal sodium and water retention, this compound expands plasma volume. ahajournals.org This increase in intravascular volume contributes to a rise in cardiac output and, consequently, an elevation in blood pressure. derangedphysiology.comresearchgate.net

Vascular Effects: this compound has direct effects on blood vessels. It can increase the sensitivity of vascular receptors to circulating pressor agents like norepinephrine. taylorandfrancis.com Research indicates it potentiates the vasoconstrictive effect of norepinephrine, contributing further to hypertension. ahajournals.org Mineralocorticoid stimulation also promotes the expression of adhesion molecules (VCAM-1, ICAM-1, and P-selectin) by endothelial cells, which are involved in leukocyte adhesion. frontiersin.org

Direct Cardiac Effects: Beyond hemodynamic changes, long-term exposure to high levels of mineralocorticoids can have direct, volume-independent effects on the heart. ahajournals.org Research suggests that this compound may promote cardiac fibrosis, oxidative stress, and endothelial dysfunction, which can contribute to adverse cardiac remodeling. ahajournals.org

Central Nervous System

This compound can cross the blood-brain barrier and exert significant effects within the central nervous system (CNS). The mechanisms in the brain differ from those in the kidney, primarily due to differences in enzyme expression.

Receptor Activation in the Brain: Many areas of the brain that express MR, such as the hippocampus, have minimal or no expression of the protective 11β-HSD2 enzyme. mdpi.com Consequently, in the CNS, cortisol is the primary endogenous ligand for the MR. bioscientifica.comwits.ac.za this compound acts as a potent MR agonist in the brain, capable of influencing neuronal function. oup.comfrontiersin.org

Neuroendocrine Regulation: this compound can modulate the activity of the hypothalamic-pituitary-adrenal (HPA) axis. Studies have shown that as an MR agonist, it can exert a strong inhibitory effect on both ACTH and cortisol secretion, suggesting it reinforces the negative feedback loop at a suprapituitary level. oup.com

Neuronal Plasticity and Survival: Research in cellular models has revealed direct effects of this compound on neuronal cells. One study found that this compound promotes the survival and proliferation of adult hippocampal progenitor cells. frontiersin.org This effect was mediated by the MR and involved signaling pathways such as cAMP/PKA/CREB and PI3K/Akt. frontiersin.org Furthermore, the study demonstrated that this compound could attenuate the detrimental effects of amyloid-β peptide on cell survival and block the hyperphosphorylation of Tau protein, a key feature in some neurodegenerative diseases. frontiersin.org

Table 2: Summary of Tissue-Specific Actions of this compound

TissuePrimary Receptor TargetKey MechanismsMajor Physiological Outcomes
Kidney Mineralocorticoid Receptor (MR)Upregulation of ENaC and Na+/K+-ATPase; action protected by 11β-HSD2Sodium and water retention; potassium and hydrogen excretion
Cardiovascular System Mineralocorticoid Receptor (MR)Plasma volume expansion; increased vascular sensitivity to pressors; potential for direct cardiac fibrosis and endothelial dysfunctionIncreased blood pressure; vascular and cardiac remodeling
Central Nervous System Mineralocorticoid Receptor (MR)Direct binding to MR (unprotected by 11β-HSD2); HPA axis inhibition; activation of pro-survival signaling pathwaysModulation of neuroendocrine function; potential neuroprotective effects

Physiological Systemic Regulation by Fludrocortisone

Renin-Angiotensin-Aldosterone System (RAAS) Interplay

The RAAS is a critical hormonal cascade that governs blood pressure, fluid balance, and electrolyte levels. Fludrocortisone significantly interacts with this system. As a mineralocorticoid, it promotes sodium and water retention, which, through feedback mechanisms, can lead to a suppression of renin release from the kidneys nih.govdroracle.aimedscape.com. Renin is the rate-limiting enzyme in the RAAS, initiating the conversion of angiotensinogen to angiotensin I, which is subsequently converted to angiotensin II. Angiotensin II is a potent vasoconstrictor and stimulates aldosterone secretion from the adrenal cortex droracle.ainih.gov.

Studies indicate that this compound administration is associated with a marked decrease in plasma renin activity (PRA) and plasma renin concentration (PRC) nih.govoup.comd-nb.info. For instance, in healthy volunteers, PRC levels were significantly lower when treated with this compound compared to placebo, with higher doses leading to more pronounced reductions d-nb.info. This suppression of renin is a consequence of the increased extracellular fluid volume and elevated blood pressure resulting from this compound's mineralocorticoid actions, which signal to the kidneys to reduce renin production droracle.aimedscape.com. In patients with primary adrenal insufficiency, plasma renin activity is often used as a marker to titrate this compound dosage, with elevated renin suggesting insufficient mineralocorticoid replacement and suppressed renin indicating potential over-replacement d-nb.infonih.govfrontiersin.org. Conversely, conditions like low blood volume, which should normally activate the RAAS, may show paradoxical low renin and aldosterone levels in certain disorders, where this compound acts to enhance aldosterone effects ahajournals.org.

Electrolyte Homeostasis Regulation (Sodium and Potassium Dynamics)

This compound plays a central role in maintaining electrolyte balance, primarily by acting on the renal distal tubules and collecting ducts nih.govdroracle.ai. Its potent mineralocorticoid activity leads to increased reabsorption of sodium (Na+) and water from the renal tubules, thereby expanding the extracellular fluid volume droracle.airesearchgate.netoup.comnih.gov. Concurrently, this compound promotes the excretion of potassium (K+) and hydrogen ions (H+) into the urine nih.govdroracle.ainih.govnice.org.uk.

This action on sodium and potassium balance is dose-dependent and can lead to significant alterations in serum electrolyte concentrations if not carefully managed. Studies have demonstrated a positive linear correlation between this compound dose and serum sodium levels, and a negative correlation with serum potassium levels nih.gov. This compound can cause hypokalemia, with nearly 50% of patients experiencing this electrolyte disturbance, often within the first week of treatment nih.gov. The drug's effect on urinary electrolyte excretion is substantial, as shown by significant decreases in urinary sodium and potassium levels following administration.

ElectrolyteChangeTime Point
Urinary SodiumDecreased by approximately 58%4 hours
Urinary SodiumDecreased by approximately 28%10 hours
Urinary PotassiumDecreased by approximately 35%8 hours
Urinary PotassiumDecreased by approximately 24%12 hours

Data adapted from nih.gov and.

The increased sodium retention contributes to plasma volume expansion, while the increased potassium excretion can lead to hypokalemia, necessitating careful monitoring of electrolyte levels and potential potassium supplementation droracle.ainice.org.uk.

Volume Regulation and Hemodynamic Effects

A primary effect of this compound is the expansion of plasma volume. By enhancing renal sodium and water reabsorption, the drug increases the body's total extracellular fluid volume, which in turn leads to an expansion of the intravascular space oup.comdroracle.airesearchgate.netoup.com. This volume expansion is a key mechanism by which this compound helps to increase blood pressure and improve circulatory status, particularly in conditions like orthostatic hypotension where there is impaired blood volume regulation researchgate.netoup.com. While the initial increase in plasma volume is a direct consequence of sodium and water retention, it can be transient due to a phenomenon known as "mineralocorticoid escape," where renal mechanisms partially counteract the sustained effects on sodium balance oup.com.

Beyond its effects on fluid volume, this compound also modulates vascular tone and responsiveness. It is known to increase vascular alpha-adrenergic receptor sensitivity, thereby potentiating the vasoconstrictive effects of endogenous catecholamines such as norepinephrine frontiersin.orgdroracle.airesearchgate.net. This enhanced sensitivity to vasoconstrictors contributes to an increase in peripheral vascular resistance and can lead to elevated blood pressure oup.comdroracle.airesearchgate.net. Research has shown that this compound administration can increase pressor responsiveness to norepinephrine and angiotensin II infusions frontiersin.orgresearchgate.net.

These actions contribute to this compound's ability to raise blood pressure, particularly in the upright position, which is beneficial in managing orthostatic hypotension oup.com. However, this potentiation of vasoconstriction can also contribute to adverse effects such as supine hypertension nih.gov.

Table 2: this compound's Influence on Hemodynamic Parameters and Renin Activity

ParameterBaseline/Control ValueThis compound ValueChange/EffectSource(s)
Hemodynamic Parameters
Cardiac Output5.0 L/min6.0 L/minIncreased researchgate.net
Mean Arterial Pressure82 mm Hg91 mm HgIncreased researchgate.net
Tilted Systolic BP~110 mmHg~140-150 mmHgIncreased (~30-40 mmHg)
Tilted Diastolic BP~76 mmHg~86 mmHgIncreased (~10 mmHg)
Systemic Vascular ResistanceNot specifiedIncreasedIncreased droracle.ai
Heart RateNot specifiedDecreasedDecreased droracle.ai
Renin Activity/Concentration
Plasma Renin Concentration (PRC)Placebo: 54.2 ± 57.9 ng/mL/h0.1 mg FC: 15.2 ± 25.9 ng/mL/hDecreased with increasing FC dose d-nb.info
Plasma Renin Concentration (PRC)Placebo: 54.2 ± 57.9 ng/mL/h0.2 mg FC: 5.5 ± 5.7 ng/mL/hDecreased with increasing FC dose d-nb.info
Plasma Renin ActivitySubnormal (orthostatic stress)Lower (after treatment)Further suppressed oup.com
Plasma Renin ActivityNot specifiedSignificantly lowerAssociated with hypertension in children

Note: Hemodynamic effects can vary depending on the dose and specific clinical context. In some studies, this compound at doses used for septic shock showed no significant systemic hemodynamic effects, unlike hydrocortisone nih.gov. Data for renin activity/concentration illustrate the suppressive effect of this compound.

Compound List:

this compound

Aldosterone

Cortisol

Norepinephrine

Angiotensin II

Hydrocortisone

Dexamethasone

Mechanistic Insights from Clinical Research and Therapeutic Explorations of Fludrocortisone

Adrenocortical Insufficiency and Mineralocorticoid Replacement Mechanisms

Adrenocortical insufficiency, encompassing primary conditions like Addison's disease, is defined by the inadequate production of corticosteroids, including the vital mineralocorticoid aldosterone. drugbank.com Aldosterone plays a crucial role in maintaining electrolyte and water balance by acting on the kidneys to promote sodium reabsorption and potassium excretion. drugbank.compatsnap.com In its absence, patients can suffer from dehydration, low blood pressure, and dangerous electrolyte imbalances. tijer.org

Fludrocortisone serves as a potent replacement for endogenous aldosterone. drugbank.com Its primary mechanism of action involves binding to mineralocorticoid receptors located in the distal tubules and collecting ducts of the kidneys. patsnap.comdroracle.ai This interaction initiates a cascade of cellular events that lead to the increased reabsorption of sodium ions from the urine back into the bloodstream. patsnap.com As sodium is reabsorbed, water follows osmotically, leading to an expansion of the extracellular fluid volume and a subsequent increase in blood pressure. patsnap.commedex.com.bd Simultaneously, this compound promotes the excretion of potassium and hydrogen ions into the urine, helping to correct the hyperkalemia often seen in adrenal insufficiency. mims.compediatriconcall.com

The structural design of this compound, specifically the presence of a fluorine atom at the 9-alpha position of the steroid structure, confers upon it very potent mineralocorticoid activity, making it highly effective as a replacement therapy. drugbank.comedcentral.co Its effects on electrolyte balance are considerably heightened and prolonged compared to naturally occurring corticosteroids. pediatriconcall.comedcentral.co By restoring sodium and water retention, this compound effectively mitigates the symptoms of aldosterone deficiency, such as hypotension and salt-wasting. tijer.org

Orthostatic Hypotension: Underlying Mechanisms of Efficacy

Orthostatic hypotension is a condition characterized by a significant drop in blood pressure upon standing, leading to symptoms like dizziness, lightheadedness, and fainting. tijer.orgnih.gov It often results from autonomic nervous system dysfunction, where the body's mechanisms for regulating blood pressure are impaired. tijer.org this compound is a first-line pharmacological treatment for this condition. cochranelibrary.comwikipedia.org

Volume Expansion and Blood Pressure Stabilization Mechanisms

Clinical research has demonstrated the effectiveness of this compound in stabilizing blood pressure in individuals with orthostatic hypotension. Studies have shown that treatment with this compound can reduce the magnitude of the blood pressure drop upon standing. cochranelibrary.com This effect is primarily attributed to the retention of sodium and the subsequent increase in blood volume. nice.org.uk

Sympathetic Nervous System Sensitization Mechanisms

Beyond its direct effects on volume expansion, there is evidence to suggest that this compound may also enhance the body's response to its own vasoconstrictive signals. It is postulated that this compound potentiates the pressor effects of endogenous vasoconstrictors like norepinephrine and angiotensin II. nih.govjmatonline.com This sensitization of the vasculature to catecholamines means that blood vessels can constrict more effectively in response to sympathetic nervous system signals when a person stands up, helping to maintain blood pressure. nih.govahajournals.org

This dual mechanism of action—expanding blood volume and increasing vascular sensitivity—underpins the efficacy of this compound in managing the debilitating symptoms of orthostatic hypotension. nih.govahajournals.org

Septic Shock: Immunomodulatory and Hemodynamic Mechanisms

Septic shock is a life-threatening condition characterized by a dysregulated host response to infection, leading to dangerously low blood pressure and organ dysfunction. nih.gov The use of corticosteroids, including this compound in combination with hydrocortisone, has been explored for its potential to improve outcomes in these critically ill patients.

Vasopressor Responsiveness Enhancement Mechanisms

A key challenge in managing septic shock is the reduced responsiveness of blood vessels to vasopressors, the medications used to constrict blood vessels and raise blood pressure. Research suggests that the addition of this compound to hydrocortisone therapy may improve vascular responsiveness to these agents. clinicaltrials.gov One hypothesis is that this compound enhances the pressor response to catecholamines, similar to its proposed mechanism in orthostatic hypotension. centerwatch.com By increasing the sensitivity of the vasculature to vasopressors, this compound may help to stabilize hemodynamics and reduce the required dose of these potent drugs. clinicaltrials.gov

A study in healthy volunteers with induced hypoaldosteronism, mimicking a condition seen in septic shock, showed that this compound could significantly improve the pressor response to phenylephrine. centerwatch.com However, another study with a similar design reported a decrease in the pressor response. nih.gov The FluDReSS (this compound Dose–Response Relationships and Vascular Responsiveness in Septic Shock) study was designed to further investigate whether adding this compound to hydrocortisone improves vascular responsiveness to vasopressors in a dose-dependent manner in patients with septic shock. clinicaltrials.govspringermedizin.de

Distinct Glucocorticoid and Mineralocorticoid Effects in Critical Illness

The rationale for combining this compound with hydrocortisone in septic shock lies in their distinct yet complementary actions. nih.gov Hydrocortisone provides both glucocorticoid and some mineralocorticoid activity, while this compound offers potent mineralocorticoid effects. nih.gov Some researchers argue that the 200mg daily dose of hydrocortisone used in septic shock should provide sufficient mineralocorticoid activity, making additional this compound unnecessary. wikijournalclub.org

However, other evidence suggests that the combination therapy may offer benefits beyond simple mineralocorticoid replacement. nih.govatsjournals.org The APROCCHSS trial, for instance, found that the combination of intravenous hydrocortisone and enteral this compound led to a reduction in 90-day mortality compared to placebo. springermedizin.de The potential mechanisms for this are not fully understood but may involve mineralocorticoid receptor isoforms that bind to this compound but not hydrocortisone, or effects outside of the kidney, such as inhibiting IL-1 production in the lungs and activating the innate immune system. atsjournals.org

A retrospective cohort study analyzing a large healthcare database found that patients with septic shock treated with a combination of hydrocortisone and this compound had lower rates of a composite outcome of hospital death or discharge to hospice compared to those who received hydrocortisone alone. sccm.org This suggests that this compound may have pleiotropic effects, including facilitating the clearance of lung edema in acute respiratory distress syndrome, a common complication of septic shock. sccm.orgemra.org

The following table summarizes key findings from a randomized phase II trial (FluDReSS) investigating the dose-response relationship of this compound in septic shock:

OutcomeHydrocortisone Alone+50 µg this compound+100 µg this compound+200 µg this compound
Number of Patients 38423637
Median Time to Shock Resolution (days) 3333
28-Day Mortality Rate 24% (9/38)17% (7/42)11% (4/36)11% (4/37)
Data from the FluDReSS trial as reported in a 2024 publication. springermedizin.de

While the FluDReSS trial did not find a significant difference in the primary outcome of time to shock resolution between the groups, it did note a trend towards lower mortality with the addition of this compound. springermedizin.de The study also confirmed that enterally administered this compound resulted in detectable plasma concentrations in the majority of critically ill patients. researchgate.net

Further research from a retrospective registry study provides additional insights into the comparative effectiveness of hydrocortisone with and without this compound in septic shock:

OutcomeHydrocortisone + this compound (n=2,280)Hydrocortisone Alone (n=85,995)Adjusted Risk Difference
In-Hospital Mortality or Discharge to Hospice 47.2%50.8%-3.7%
Data from a retrospective registry study published in 2023. wikijournalclub.org

This large observational study found that the addition of this compound was associated with a statistically significant lower risk of in-hospital mortality or discharge to hospice. wikijournalclub.org

Novel Therapeutic Avenues and Mechanistic Investigations

Recent research has illuminated potential new uses for this compound, grounded in its distinct molecular and physiological effects. The following sections explore the mechanistic hypotheses driving the investigation of this compound in several distinct and challenging medical conditions.

Traumatic brain injury (TBI) triggers a complex secondary injury cascade, a major component of which is a pronounced neuroinflammatory response. surgicalneurologyint.comsurgicalneurologyint.com This inflammation, largely mediated by immune cells in the brain called microglia, can exacerbate initial damage and hinder recovery. frontiersin.org A key therapeutic strategy involves modulating this inflammatory response.

This compound, primarily known for its potent mineralocorticoid activity, is being investigated for its potential neuroprotective and anti-inflammatory roles in TBI. nih.gov The central hypothesis is that this compound can beneficially alter the behavior of microglia. Following injury, microglia can adopt different functional states, or phenotypes. The "M1" phenotype is pro-inflammatory, releasing damaging cytokines, while the "M2" phenotype is anti-inflammatory and promotes tissue repair.

Research in animal models of TBI suggests that this compound, acting as a specific mineralocorticoid receptor (MR) agonist, promotes a shift in the microglial phenotype from the detrimental M1 state to the beneficial M2 state. nih.gov This targeted modulation, rather than broad immunosuppression, is thought to be key to its therapeutic potential. The proposed molecular pathway for this phenotype switch involves the JAK/STAT6/PPARγ pathway . nih.gov By activating this pathway, this compound is hypothesized to suppress neuroinflammation, enhance the formation of new blood vessels (angiogenesis), and promote the survival of neurons, ultimately leading to better functional recovery after TBI. nih.gov

Idiopathic sudden sensorineural hearing loss (SNHL) is a challenging condition with no definitive cure. nih.govclinicaltrials.gov While the exact causes are often unknown, leading theories point to issues like impaired blood flow or viral infections. mdpi.com A more recent and compelling hypothesis centers on the disruption of the delicate ionic balance within the inner ear's fluids, a state known as ionic homeostasis. nih.govclinicaltrials.gov

The inner ear contains corticoid receptors, for both mineralocorticoids and glucocorticoids, suggesting that these hormones play a role in its normal function. nih.govclinicaltrials.gov The primary mechanistic hypothesis for this compound in treating sudden hearing loss is its ability to restore cochlear ion homeostasis through its strong mineralocorticoid effects. nih.govclinicaltrials.gov The auditory end organs require tightly regulated fluids (endolymph and perilymph) to function correctly, and this regulation is influenced by mineralocorticoid receptors. mycancergenome.org

It is proposed that by acting on these receptors, this compound helps to re-establish the normal ionic concentrations necessary for the proper function of the cochlea's sensory cells. nih.govclinicaltrials.gov Furthermore, steroids can promote blood supply to the inner ear, and their mineralocorticoid effects, which lead to the reabsorption of sodium and water, may increase blood flow, providing an additional beneficial mechanism. mdpi.commycancergenome.org

Aneurysmal subarachnoid hemorrhage (SAH) is a life-threatening condition where a brain aneurysm ruptures. A common and dangerous complication following SAH is the development of hyponatremia (low sodium levels) and natriuresis (excessive sodium loss in urine), a condition often termed cerebral salt wasting (CSW). frontiersin.orgclevelandclinic.org This imbalance can lead to a decrease in plasma volume, which in turn increases the risk of cerebral vasospasm and subsequent ischemic brain damage. frontiersin.orgclevelandclinic.org

The therapeutic mechanism of this compound in this setting is directly related to its potent mineralocorticoid activity and its role in restoring sodium homeostasis. clevelandclinic.orgnih.gov By acting on the kidneys, this compound enhances the reabsorption of sodium and water from the tubular fluid back into the plasma. nih.govcenterwatch.com This action counteracts the pathological sodium loss seen in CSW.

The primary mechanistic hypotheses are:

Reduction of Natriuresis : this compound directly reduces the excretion of sodium in the urine. frontiersin.orgcenterwatch.com

Maintenance of Plasma Volume : By promoting sodium and water retention, this compound helps to maintain or restore adequate intravascular volume. frontiersin.orgnih.gov This is crucial for preventing delayed cerebral ischemia, a major cause of morbidity and mortality in SAH patients. clevelandclinic.org

Clinical research suggests that corticosteroids with mineralocorticoid activity, like this compound, can decrease natriuretic diuresis and the incidence of hypovolemia in SAH patients. clevelandclinic.org

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterized by the progressive loss of retinal cells. nih.govresearchgate.net A key factor in the pathogenesis of GA is chronic inflammation within the retina, driven by the elevation of pro-inflammatory cytokines. nih.govresearchgate.netnih.gov

This compound is being explored as a potential therapeutic for GA due to its demonstrated anti-inflammatory and neuroprotective properties in preclinical models. nih.govresearchgate.netneurosciencenews.com The mechanistic hypotheses are twofold:

Anti-inflammatory Effects : Research has shown that this compound can dramatically reduce the expression of key pro-inflammatory cytokines, such as CCL2, IL-6, and IL-8 , in retinal Müller glia cells when challenged with inflammatory stimuli. nih.govresearchgate.net Interestingly, while this compound is an agonist for both mineralocorticoid and glucocorticoid receptors, studies using selective antagonists revealed that this potent anti-inflammatory effect is mediated primarily through glucocorticoid receptor signaling . nih.govresearchgate.net

Neuroprotective Mechanisms : Beyond its anti-inflammatory action, this compound has shown direct neuroprotective properties. In a mouse model of photo-oxidative damage, which mimics aspects of outer retinal degeneration seen in AMD, intravitreal this compound was found to preserve the outer nuclear layer of the retina and photoreceptor function. neurosciencenews.comwikipedia.org This suggests it can directly protect retinal neurons from cell death. nih.gov

These findings indicate that this compound may slow the progression of GA by simultaneously suppressing the chronic inflammation that drives the disease and protecting retinal cells from degeneration. researchgate.net

Successful embryo implantation requires a receptive endometrium, a state achieved through a complex and synchronized series of molecular events known as the "window of implantation." surgicalneurologyint.comdrugbank.comoup.com Research in mouse models suggests that this compound may improve endometrial receptivity by modulating the expression of specific genes and signaling pathways.

The proposed molecular mechanism involves the regulation of several key players in the implantation process. Studies indicate that this compound treatment can:

Downregulate specific genes and microRNAs : It has been shown to slightly decrease the expression of SGK1 , ENaC-α , miR-145 , and miR-200a . SGK1 and ENaC are involved in ion and fluid transport, while miR-145 and miR-200a are microRNAs that can negatively regulate genes essential for implantation. Downregulation of these factors is hypothesized to create a more favorable environment for the embryo.

Upregulate receptivity-associated factors : this compound appears to slightly increase the expression of HAND2 and miR-451 . The transcription factor HAND2 is crucial for uterine receptivity.

Activate a key signaling pathway : The treatment has been shown to increase the activation of the mTOR signaling pathway , evidenced by higher levels of mTOR and its downstream target 4E-BP1 . The mTOR pathway is a central regulator of cell growth and proliferation and is believed to play an essential role in establishing endometrial receptivity.

In essence, the hypothesis is that this compound fine-tunes the molecular environment of the endometrium, shifting the balance of gene expression to enhance uterine receptivity and facilitate successful implantation.

Glioblastoma (GBM) is the most aggressive primary brain tumor, known for its rapid growth and resistance to therapy. mdpi.com Identifying novel molecular targets to inhibit its proliferation is a critical area of cancer research. nih.gov While the role of this compound in directly treating GBM is not well-established, some preclinical findings in other cell types suggest potential, though hypothetical, molecular targets.

A study on embryonic cells demonstrated that both dexamethasone and this compound can inhibit the Hedgehog signaling pathway . This pathway is crucial during embryonic development and can be aberrantly reactivated in some cancers, including certain types of brain tumors, to drive cell proliferation. While this provides a potential mechanistic hypothesis, direct evidence of this compound inhibiting GBM cell proliferation via this or any other specific molecular target is currently lacking in published research.

Clinical trial information for GBM sometimes lists mineralocorticoids like this compound as an allowed medication for patients, but this is typically for managing other conditions such as adrenal insufficiency or orthostatic hypotension, not as an anti-cancer agent itself. mycancergenome.orgcenterwatch.com Therefore, the investigation of this compound's direct molecular targets for inhibiting GBM cell proliferation represents a novel and largely unexplored therapeutic avenue.

Data Tables

Table 1: Summary of Mechanistic Hypotheses for this compound

Condition Primary Mechanistic Hypothesis Key Molecular Pathways/Targets
Traumatic Brain Injury Induces a shift in microglia phenotype from pro-inflammatory (M1) to anti-inflammatory (M2). nih.gov Activation of the JAK/STAT6/PPARγ pathway. nih.gov
Sudden Hearing Loss Restoration of cochlear ionic homeostasis. nih.govclinicaltrials.gov Action on mineralocorticoid receptors in the inner ear. nih.govclinicaltrials.gov
Aneurysmal Subarachnoid Hemorrhage Reduction of natriuresis and maintenance of plasma volume. frontiersin.orgclevelandclinic.org Enhanced sodium and water reabsorption via mineralocorticoid action. nih.govcenterwatch.com
Geographical Atrophy (AMD) Suppression of retinal inflammation and direct neuroprotection. nih.govresearchgate.netneurosciencenews.com Inhibition of CCL2, IL-6, IL-8 via glucocorticoid receptor signaling. nih.govresearchgate.net
Endometrial Receptivity Modulation of gene expression to favor implantation. Regulation of SGK1, ENaC, HAND2, miR-145, miR-200a, miR-451; Activation of mTOR pathway.

| Glioblastoma (GBM) | Inhibition of pro-proliferative signaling (Hypothetical). | Potential inhibition of the Hedgehog signaling pathway (not confirmed in GBM). |

Table 2: List of Compounds Mentioned

Compound Name
4E-BP1
Aldosterone
CCL2
Dexamethasone
ENaC-α
This compound
HAND2
Hydrocortisone
IL-6
IL-8
mTOR
PPARγ
SGK1

Comparative Pharmacodynamics and Pharmacokinetics in Research

Comparison with Endogenous Aldosterone (Potency and Effects)

Fludrocortisone is a potent synthetic mineralocorticoid that is structurally similar to cortisol, with the addition of a fluorine atom at the 9-alpha position. nih.gov This modification significantly enhances its mineralocorticoid activity, making it functionally analogous to aldosterone, the body's primary endogenous mineralocorticoid. nih.govdrugbank.com

In terms of potency, research indicates that this compound possesses a mineralocorticoid activity that is as powerful as, and in some reports, 10-fold higher than, endogenous aldosterone. nih.govoup.com This potent activity leads to marked sodium retention and increased urinary excretion of potassium, effects that are central to its therapeutic use in replacing aldosterone in conditions of adrenal insufficiency. drugbank.comnih.govmims.com The physiological actions of this compound are similar to those of hydrocortisone, but its effects, particularly on electrolyte balance, are considerably heightened and prolonged. mims.com

While both aldosterone and this compound are classified as mineralocorticoids, their pharmacological actions exhibit some differences which may translate into distinct clinical effects. nih.gov For instance, the duration of action of this compound is longer than that of aldosterone, which makes it more suitable for clinical applications. nih.gov Furthermore, this compound has been observed to inhibit pituitary adrenocorticotropic hormone (ACTH), a glucocorticoid-like effect not seen with aldosterone. nih.gov

The binding affinity of this compound to the mineralocorticoid receptor (MR) is a key determinant of its potent effects. In rat studies, this compound demonstrated an affinity for the MR that is approximately 15 times higher than that of the natural hormone, aldosterone. nih.gov This high affinity contributes to its profound mineralocorticoid potency. drugbank.com

Comparative Analysis with Other Synthetic Corticosteroids (e.g., Hydrocortisone, Prednisone)

This compound is a unique synthetic corticosteroid characterized by its potent mineralocorticoid and substantial glucocorticoid activity. nih.gov When compared to other synthetic corticosteroids like hydrocortisone and prednisone, the most striking difference lies in its mineralocorticoid-to-glucocorticoid activity ratio.

This compound exhibits exceptionally high mineralocorticoid potency relative to its glucocorticoid effects. nih.gov Its mineralocorticoid potency is estimated to be 125 to 800 times that of hydrocortisone. wikipedia.orgtokyovets.com In contrast, its glucocorticoid potency is approximately 10 to 15 times that of hydrocortisone. nih.govtokyovets.com This makes this compound the corticosteroid with the strongest mineralocorticoid effect. sccm.org

Prednisone, another synthetic corticosteroid, primarily exerts glucocorticoid effects with minimal mineralocorticoid activity. drugs.comdroracle.ai This distinction is crucial in clinical settings; this compound is utilized for its mineralocorticoid replacement effects, while prednisone is prescribed for its anti-inflammatory and immunosuppressive glucocorticoid actions. droracle.ai

The following table provides a comparative overview of the relative potencies of various corticosteroids.

AgentEquivalent Dose (mg)Anti-inflammatory (Glucocorticoid) PotencyMineralocorticoid Potency
Hydrocortisone2011
Cortisone250.80.8
This compound 2 10 250
Prednisone540.3
Prednisolone550.3
Methylprednisolone450.25
Triamcinolone450
Dexamethasone0.75250
Betamethasone0.625-400
Data sourced from a comparative table of synthetic steroid doses and potencies. litfl.com

The differential effects of corticosteroids are rooted in their binding affinities for glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). Cortisol, the endogenous glucocorticoid, binds to both GR and MR. nih.gov Synthetic glucocorticoids such as prednisone, prednisolone, and dexamethasone have a lower affinity for corticosteroid-binding globulin (CBG) compared to cortisol, leading to higher free fractions in the plasma. nih.gov

This compound also has a lower affinity for CBG. nih.gov While it binds to both GR and MR, its affinity for the MR is significantly greater, which accounts for its potent mineralocorticoid effects at low doses. nih.govnih.gov In contrast, hydrocortisone has a more balanced affinity for both receptors. nih.gov The 9α-fluorination of this compound appears to protect it from 11β-oxidation by 11-hydroxysteroid dehydrogenases, a reaction that inactivates cortisol. This reduced inactivation is thought to be a primary reason for this compound's profound mineralocorticoid potency. drugbank.com

Differential Mineralocorticoid to Glucocorticoid Ratios

Pharmacodynamic Differences and Clinical Implications in Research Settings

The distinct pharmacodynamic properties of this compound have significant implications for its application in research, particularly concerning its duration of action and bioavailability.

This compound has a prolonged duration of action, with a biological half-life estimated to be between 18 and 36 hours. mims.comdroracle.airxlist.com A single dose can exert its effects over one to two days. drugbank.commims.commims.com This extended duration is a key difference compared to the shorter-acting endogenous aldosterone. nih.gov This long half-life is a result of the fluorination of the molecule, which creates inert bonds. nih.gov

The following table summarizes the duration of action for different corticosteroids.

CorticosteroidDuration of Action
Short-acting (8-12 hours) Cortisone, Hydrocortisone
Intermediate-acting (12-36 hours) This compound , Prednisone, Prednisolone, Methylprednisolone, Triamcinolone
Long-acting (36-72 hours) Betamethasone, Dexamethasone
Data sourced from a steroid conversion chart. litfl.com

This compound is administered orally and is generally considered to have good absorption from the gastrointestinal tract. drugbank.comnih.gov Some research suggests its oral bioavailability is 100%. nih.gov However, other sources indicate that it undergoes extensive first-pass metabolism in the liver, which could result in lower systemic bioavailability. The absorption of this compound can be influenced by factors such as food intake, with high-fat meals potentially enhancing absorption.

In research settings, particularly in studies involving critically ill patients, the bioavailability of orally administered this compound can be a concern. For example, one study in patients with septic shock found that a single oral dose resulted in undetectable plasma levels in one-third of the participants. nih.gov This highlights the importance of considering the route of administration and potential absorption issues when designing and interpreting research involving this compound.

Compound Names

Aldosterone

Betamethasone

Cortisol

Cortisone

Dexamethasone

this compound

Hydrocortisone

Methylprednisolone

Prednisolone

Prednisone

Triamcinolone

Duration of Action

Protein Binding and Distribution in Research Models

In research models, this compound demonstrates significant binding to plasma proteins, a characteristic that influences its bioavailability and distribution. Approximately 70-80% of this compound in the plasma is bound to proteins, primarily corticosteroid-binding globulin (CBG) and, to a lesser extent, albumin. drugbank.comnih.gov However, synthetic glucocorticoids like this compound exhibit a lower affinity for CBG compared to endogenous cortisol. tg.org.aunih.gov This lower affinity results in a higher free fraction of the drug, which may contribute to its potent mineralocorticoid activity. nih.gov

The apparent volume of distribution for this compound is estimated to be between 80 and 85 liters, indicating extensive tissue distribution. drugbank.comnih.gov Despite its wide distribution, penetration into the cerebrospinal fluid (CSF) appears to be minimal. drugbank.comnih.gov Studies in human volunteers have shown that the concentration ratio of this compound in the CSF to that in the plasma is 1:6. drugbank.commedicines.org.uk In animal models, such as mice, tissue distribution analysis has shown that this compound is distributed to various organs, including the liver, kidney, spleen, and lung, with smaller amounts found in the brain. researchgate.net

Estrogens can increase the levels of corticosteroid-binding globulin, which in turn increases the bound, inactive fraction of corticosteroids. rxlist.com This necessitates adjustments in corticosteroid dosage when estrogen therapy is initiated or terminated. medicines.org.ukrxlist.commedsafe.govt.nz

Below is an interactive data table summarizing the protein binding and distribution parameters of this compound.

ParameterValueSpecies/Model
Protein Binding 70-80%Human
Primary Binding Proteins Corticosteroid-binding globulin (CBG), AlbuminHuman
Apparent Volume of Distribution 80-85 LHuman
CSF to Plasma Concentration Ratio 1:6Human Volunteers

Metabolism Pathways and Metabolite Activity in Research Contexts

The metabolism of this compound is primarily hepatic and appears to be less complex than that of other corticosteroids. drugbank.comnih.gov The 9α-fluorination of the this compound molecule significantly hinders oxidation by 11β-hydroxysteroid dehydrogenase enzymes. drugbank.comnih.gov This reduced 11β-oxidation is thought to be a key factor in its potent mineralocorticoid effects. drugbank.comnih.gov this compound acetate, a prodrug, requires hydrolysis by esterases in the liver and other tissues to become active this compound. nih.gov

In vitro studies using human liver microsomes and cytosol have identified two primary metabolites: 20β-dihydrofluorocortisol and 6β-hydroxyfluorocortisol. drugbank.comnih.gov While the specific enzymes responsible for these transformations have not been fully elucidated, the cytochrome P450 system, particularly the CYP3A4 enzyme, is believed to play a significant role in this compound metabolism. drugbank.com This is supported by observed interactions with drugs that induce or inhibit CYP3A4. rxlist.commedsafe.govt.nz For instance, hepatic enzyme inducers like barbiturates, phenytoin, and rifampin can increase the metabolic clearance of this compound. rxlist.comhweclinicalguidance.nhs.uke-lactancia.org Conversely, substances that inhibit CYP3A4, such as ketoconazole, can decrease its clearance. medicines.org.uke-lactancia.org

The major metabolites of this compound, including 3-keto-fludrocortisone and its tetrahydro and dihydro derivatives, are less potent in their mineralocorticoid activity compared to the parent compound. In research settings, animal models are utilized to study these metabolic pathways. For example, studies in dogs have shown a triphasic decline in blood concentration after administration of this compound acetate, with each phase potentially representing the elimination of a different metabolite. medicines.org.uk

The following table outlines the known metabolites and metabolic pathways of this compound.

MetaboliteMetabolic PathwayKey Enzymes (Putative)
20β-dihydrofluorocortisol ReductionNot fully elucidated
6β-hydroxyfluorocortisol OxidationNot fully elucidated
3-keto-fludrocortisone OxidationNot fully elucidated
Tetrahydro and dihydro metabolites ReductionNot fully elucidated

Elimination Routes and Clearance Studies

This compound and its metabolites are eliminated from the body through both renal and fecal routes. Approximately 80% of an administered dose is excreted in the urine, primarily as inactive metabolites, while the remaining 20% is likely eliminated through biliary or fecal pathways. drugbank.comnih.gov

Pharmacokinetic studies in healthy human volunteers have provided varying estimates for the plasma half-life of this compound, with reports ranging from approximately 1.4 to 3.5 hours or more. drugbank.comrxlist.comnih.gov However, the biological half-life is considerably longer, estimated to be between 18 and 36 hours. rxlist.commedsafe.govt.nz This extended biological half-life is due to its mechanism of action at the genomic level. drugbank.com

Population pharmacokinetic models have estimated the plasma clearance of this compound to be approximately 40.8 L/h in healthy adults. drugbank.comnih.govnih.gov Clearance can be affected by various factors. For instance, in patients with hypothyroidism, the metabolic clearance of adrenocorticoids is decreased, while it is increased in those with hyperthyroidism, potentially requiring dosage adjustments. medicines.org.ukmedsafe.govt.nzhweclinicalguidance.nhs.uk Studies in different animal models have also contributed to the understanding of this compound elimination. In dogs and guinea pigs, the majority of the dose is excreted in the urine, whereas in rats, a significant portion is excreted in the bile. medicines.org.uke-lactancia.org

Below is a data table summarizing the elimination and clearance parameters of this compound.

ParameterValueSpecies/Model
Primary Route of Elimination Renal (approx. 80%)Human
Secondary Route of Elimination Fecal/Biliary (approx. 20%)Human
Plasma Half-life 1.4 - 3.5+ hoursHuman Volunteers
Biological Half-life 18 - 36 hoursHuman
Plasma Clearance 40.8 L/hHealthy Adults

Mechanistic Basis of Fludrocortisone-associated Effects and Complications

Electrolyte Imbalances: Mechanisms of Hypokalemia and Hypernatremia

Fludrocortisone's primary mechanism for causing hypokalemia and hypernatremia involves its action on the renal tubules, specifically the distal tubules and collecting ducts drugbank.compatsnap.comnih.gov. By binding to the mineralocorticoid receptor (MR) in these segments, this compound initiates a cascade that enhances sodium reabsorption from the tubular fluid back into the plasma drugbank.compatsnap.comnih.gov. This process is mediated by an increase in the density of sodium channels (ENaC) on the apical membrane and Na+-K+-ATPase pumps on the basolateral membrane of renal tubule cells drugbank.comderangedphysiology.com. The increased sodium reabsorption is osmotically coupled to water reabsorption, leading to an expansion of extracellular fluid volume and a subsequent rise in blood pressure drugbank.compatsnap.comclinicaltrials.eu.

Concurrently, this compound promotes the excretion of potassium and hydrogen ions into the urine drugbank.compatsnap.comderangedphysiology.comrxlist.com. This increased potassium excretion, driven by the electrochemical gradient established by enhanced sodium reabsorption, can lead to hypokalemia (low serum potassium levels) drugbank.comderangedphysiology.comrxlist.com. The net effect is an increase in plasma sodium concentration and a decrease in plasma potassium concentration.

Cardiovascular Effects: Pathophysiological Insights into Hypertension, Edema, and Congestive Heart Failure

This compound's mineralocorticoid activity significantly impacts the cardiovascular system, contributing to hypertension, edema, and potentially exacerbating congestive heart failure (CHF) rxlist.comnih.govnih.govdrugs.com. These effects stem from its actions on sodium and water balance, as well as potential direct effects on cardiac and vascular tissues.

Volume-Dependent and Volume-Independent Mechanisms of Cardiovascular Impact

The cardiovascular effects of this compound can be broadly categorized into volume-dependent and volume-independent mechanisms.

Volume-Dependent Mechanisms: The primary volume-dependent mechanism is the increased sodium and water retention by the kidneys, as described in section 7.1 drugbank.compatsnap.comclinicaltrials.eunih.gov. This leads to an expansion of plasma volume and extracellular fluid, increasing venous return and cardiac preload. This expansion can contribute to elevated blood pressure (hypertension) and, in susceptible individuals, precipitate or worsen edema and congestive heart failure rxlist.comnih.govnih.govdrugs.com. This compound also potentiates the vasoconstrictive effect of norepinephrine, further contributing to increased peripheral vascular resistance and blood pressure ahajournals.orgkarger.com.

Volume-Independent Mechanisms: Emerging evidence suggests that this compound, through MR activation, can exert direct, volume-independent effects on the cardiovascular system ahajournals.orgahajournals.orgfrontiersin.orgnih.govannualreviews.orgbioscientifica.comahajournals.orgportlandpress.comahajournals.orgoup.comahajournals.orgportlandpress.comoup.comrevistanefrologia.com. The MR is expressed in various cardiovascular cells, including cardiomyocytes, vascular smooth muscle cells (VSMCs), and endothelial cells nih.govannualreviews.orgbioscientifica.comahajournals.orgoup.comportlandpress.comoup.comrevistanefrologia.comannualreviews.orgahajournals.org. In these tissues, MR activation can promote inflammation, oxidative stress, and fibrosis, independent of systemic volume expansion ahajournals.orgahajournals.orgnih.govannualreviews.orgbioscientifica.comahajournals.orgahajournals.orgoup.comahajournals.orgoup.comahajournals.org. These effects can lead to adverse cardiac remodeling, endothelial dysfunction, and increased vascular stiffness, contributing to hypertension and heart disease ahajournals.orgahajournals.orgnih.govannualreviews.orgbioscientifica.comahajournals.orgahajournals.orgoup.comahajournals.orgoup.comannualreviews.orgahajournals.org.

Cardiac Fibrosis and Oxidative Stress Pathways

This compound's mineralocorticoid activity can directly promote cardiac fibrosis and oxidative stress through MR activation in cardiac cells ahajournals.orgahajournals.orgfrontiersin.orgnih.govannualreviews.orgbioscientifica.comahajournals.orgahajournals.orgoup.comahajournals.orgportlandpress.comoup.comahajournals.orgresearchgate.net. In cardiomyocytes, MR signaling can stimulate collagen deposition via the regulation of matrix metalloproteinases (MMPs) and the TGFβ–CTGF pathway bioscientifica.com. Furthermore, MR activation in VSMCs has been linked to increased oxidative stress (ROS production) and activation of the AT1 receptor, contributing to vascular inflammation and fibrosis bioscientifica.comahajournals.org.

Studies indicate that MR activation initiates an inflammatory cascade, characterized by increased expression of inflammatory cytokines (e.g., osteopontin, cyclooxygenase 2) and oxidative stress, which precedes the development of cardiac fibrosis ahajournals.orgnih.govahajournals.orgoup.comresearchgate.net. This process can involve the upregulation of NADPH oxidase subunits researchgate.net. These volume-independent mechanisms highlight how this compound can directly contribute to cardiac remodeling and dysfunction.

Neurological Manifestations: Mechanistic Hypotheses (e.g., Headache, Dizziness)

While specific detailed mechanisms for this compound-associated neurological effects like headache and dizziness are less extensively documented compared to its electrolyte and cardiovascular effects, hypotheses involve alterations in cerebral blood flow, electrolyte shifts, and potentially direct effects of mineralocorticoids on the central nervous system clinicaltrials.eunih.gov.

The increase in blood volume and potential for supine hypertension due to this compound's mineralocorticoid activity could indirectly lead to headaches or dizziness in some individuals clinicaltrials.eunih.govnih.gov. Additionally, significant electrolyte imbalances, particularly hypokalemia, can manifest with neurological symptoms such as weakness and fatigue, which might contribute to sensations of dizziness rxlist.comdrugs.com.

Mineralocorticoid receptors (MRs) are also expressed in the brain, suggesting potential direct effects on neurological function annualreviews.orgresearchgate.netresearchgate.net. While the precise mechanisms by which this compound might influence these receptors in the brain to cause specific symptoms like headache or dizziness are not fully elucidated, research into MR signaling in the central nervous system is ongoing and may provide further insights clinicaltrials.eu.

Immunosuppressive Potentiation and Infection Risk Mechanisms

This compound, like other corticosteroids, can exert immunosuppressive effects by modulating immune cell function and inflammatory pathways drugbank.combmj.comaai.orgresearchgate.netnih.govfrontiersin.org. While this compound is primarily a mineralocorticoid, it does possess glucocorticoid activity, allowing it to bind to the glucocorticoid receptor (GR) drugbank.combmj.comaai.orgresearchgate.netnih.govfrontiersin.org.

GR activation leads to complex effects on the immune system. It can suppress immune responses by promoting the expression of checkpoint receptors (e.g., Tim3, PD1, Lag3, TIGIT) on CD8+ T cells, dampening their effector functions and cytokine production aai.orgresearchgate.net. Glucocorticoids can also induce apoptosis in pro-inflammatory T cells while having pro-survival effects on regulatory T cells nih.gov. Furthermore, they can suppress dendritic cell maturation, leading to tolerogenic phenotypes that impair T-cell activation nih.gov.

These actions can potentiate existing immunosuppression and increase the risk of infections, as the body's ability to mount an effective immune response against pathogens is compromised drugbank.compatsnap.com. The context-dependent nature of GR signaling means it can exert inhibitory, permissive, or stimulatory effects on host defense, depending on the specific immune cell type and stimulus frontiersin.org.

Pharmacological Interactions and Their Mechanistic Implications

This compound can interact with other medications, altering their efficacy or increasing the risk of adverse effects through various mechanisms.

Potentiation of Norepinephrine Effects: this compound enhances the vasoconstrictive effect of norepinephrine by increasing its release from sympathetic neurons and potentially sensitizing vascular α-1 receptors ahajournals.orgkarger.com. This interaction can lead to increased blood pressure.

Induction of Hepatic Enzymes: Certain drugs, such as barbiturates, phenytoin, and rifampin, can increase the metabolic clearance of this compound by inducing hepatic enzymes pediatriconcall.com. This mechanism can reduce the systemic levels and efficacy of this compound.

Electrolyte Disturbances with Digitalis Glycosides: The hypokalemia induced by this compound can potentiate the risk of arrhythmias or digitalis toxicity when co-administered with digitalis glycosides pediatriconcall.com. This is a direct consequence of altered potassium levels affecting cardiac electrophysiology.

Interaction with Aspirin: this compound may increase the ulcerogenic effect of aspirin and decrease its pharmacological effect pediatriconcall.com. The specific mechanism for this interaction is not detailed but could involve altered gastric mucosal protection or aspirin metabolism.

Anabolic Steroids: Co-administration with anabolic steroids can enhance the tendency for edema, likely due to additive effects on sodium and water retention pediatriconcall.com.

Glucocorticoid Interactions: When used concurrently with other glucocorticoids or related drugs, the potential for adverse effects, particularly those related to mineralocorticoid activity, increases rxlist.com.

Future Directions and Emerging Research Avenues for Fludrocortisone

Elucidating Unidentified Mechanisms of Action

While fludrocortisone's primary mechanism involves binding to the mineralocorticoid receptor (MR) to promote sodium and water retention patsnap.comnih.gov, research is actively pursuing a deeper understanding of its complete molecular and cellular actions. Emerging evidence suggests that this compound, much like its endogenous counterpart aldosterone, may exert effects that are independent of the classical MR pathway nih.govtubitak.gov.tr. These mineralocorticoid receptor-independent effects are an active area of investigation, potentially involving interactions with other cellular signaling cascades or receptors, such as G-protein coupled receptor 30 (GPR30) nih.govoup.com. Understanding these alternative pathways could reveal previously unrecognized physiological roles and therapeutic targets for this compound. Furthermore, studies are exploring the precise molecular interactions and downstream signaling pathways that contribute to both its mineralocorticoid and potential glucocorticoid-like effects at higher concentrations or in specific cellular contexts nih.govresearchgate.net.

Precision Medicine Approaches and Biomarker Discovery

The advancement of precision medicine necessitates the identification of biomarkers that can predict patient response, efficacy, and potential adverse events associated with this compound therapy mdpi.comresearchgate.netnih.gov. Current research is focused on identifying patient subgroups who are most likely to benefit from this compound treatment, particularly in complex conditions like septic shock or orthostatic hypotension researchgate.netclinicaltrials.eunih.govfrontiersin.orgresearchgate.net. For example, in septic shock, efforts are underway to stratify patients based on immune response profiles or specific genetic markers to guide corticosteroid therapy researchgate.netnih.gov. Biomarkers are also being investigated to optimize dosing and minimize risks, such as identifying individuals prone to electrolyte imbalances or cardiovascular complications tubitak.gov.troup.com. The integration of omics data and computational modeling holds promise for developing personalized treatment strategies for this compound mdpi.com.

Development of Novel Analogs with Enhanced Selectivity

A significant future direction involves the development of novel analogs of this compound. The goal is to create compounds that retain the desired therapeutic effects while exhibiting enhanced selectivity for specific mineralocorticoid receptor subtypes or tissues, thereby minimizing off-target actions and potential adverse effects nih.gov. Medicinal chemistry efforts are exploring modifications to the this compound structure to improve its pharmacokinetic and pharmacodynamic profiles, potentially leading to agents with greater efficacy and improved safety margins. Research into fluorinated compounds, for instance, has historically enhanced drug properties, and this approach may yield new this compound derivatives selvita.com.

Long-term Mechanistic Studies on Systemic Effects

While this compound has been used clinically for decades, a comprehensive understanding of its long-term systemic effects and their underlying mechanisms remains an area for further investigation. Studies are needed to elucidate how prolonged exposure impacts various organ systems, including the cardiovascular system, bone metabolism, and immune function patsnap.comahajournals.orgtaylorandfrancis.com. Research is also exploring potential volume-independent mechanisms through which chronic this compound use might influence cardiac remodeling, fibrosis, oxidative stress, or endothelial dysfunction ahajournals.org. Understanding these long-term mechanistic pathways is crucial for optimizing patient management and potentially identifying new therapeutic targets or strategies to mitigate cumulative effects.

Q & A

Basic Research Questions

Q. What are the key safety protocols for handling fludrocortisone acetate in laboratory settings?

  • Methodological Answer :

  • Storage : Store in a dry environment away from ignition sources, per OSHA-compliant SDS guidelines. Use airtight containers to minimize dust exposure .
  • Handling : Wear protective gloves, eye protection, and lab coats. Avoid inhalation of dust or vapors; use fume hoods for powder handling .
  • First Aid : For eye contact, rinse with water for 15 minutes; for ingestion, seek immediate medical attention. Post-exposure monitoring for 48 hours is recommended due to delayed toxicity risks .

Q. How is this compound used to model adrenal insufficiency in preclinical studies?

  • Methodological Answer :

  • Mechanistic Basis : this compound’s mineralocorticoid activity (via agonism of the mineralocorticoid receptor) mimics aldosterone, regulating sodium retention and potassium excretion. This is critical for studying electrolyte imbalances in adrenal-deficient rodent models .
  • Dosage Justification : In murine models, typical doses range from 0.1–0.3 mg/kg/day orally to replicate clinical Addison’s disease phenotypes. Monitoring urinary sodium/potassium ratios validates efficacy .

Q. What standardized assays quantify this compound’s bioactivity in vitro?

  • Methodological Answer :

  • Receptor Binding Assays : Competitive binding studies using radiolabeled aldosterone and human mineralocorticoid receptor (MR)-transfected cells. IC₅₀ values are compared to reference ligands .
  • Functional Assays : Epithelial sodium channel (ENaC) activation in kidney cell lines (e.g., MDCK), measured via electrophysiology or fluorescent sodium indicators .

Advanced Research Questions

Q. How should researchers design trials to evaluate synergistic effects of this compound with hydrocortisone in septic shock?

  • Methodological Answer :

  • Factorial Design : Use a 2x2 factorial RCT (e.g., APROCCHSS trial) to assess hydrocortisone ± this compound. Primary outcomes: 90-day mortality and vasopressor-free days .
  • Statistical Adjustments : Stratify by baseline SOFA scores and adjust for confounders (e.g., hyperglycemia) via multivariable regression. Pre-specified subgroup analyses (e.g., baseline cortisol levels) enhance generalizability .

Q. How can conflicting efficacy data for this compound in orthostatic hypotension (OH) be resolved?

  • Methodological Answer :

  • Systematic Review : Aggregate data from RCTs (e.g., Cochrane meta-analysis) and observational studies. Use GRADE criteria to assess evidence certainty, noting limitations in small sample sizes and heterogeneous endpoints (e.g., blood pressure vs. symptom relief) .
  • Sensitivity Analysis : Exclude studies with high bias risk (e.g., unblinded trials). For example, a 2019 review found insufficient evidence for OH in Parkinson’s disease due to methodological flaws in existing trials .

Q. What experimental approaches validate this compound’s role in cognitive function modulation?

  • Methodological Answer :

  • Neuropsychological Testing : Double-blind, placebo-controlled trials administering low-dose this compound (0.1–0.2 mg/day) to assess executive function (e.g., Stroop test) and verbal memory (e.g., Rey Auditory Verbal Learning Test) .
  • Biomarker Correlation : Measure salivary cortisol levels pre/post-intervention. Reduced cortisol secretion post-fludrocortisone correlates with improved cognitive outcomes, suggesting MR-mediated neuroprotection .

Q. How is the this compound suppression test optimized for diagnosing primary aldosteronism?

  • Methodological Answer :

  • Protocol : Administer 0.1 mg this compound every 6 hours for 4 days with sodium supplementation. Measure plasma aldosterone and renin activity on day 4. A suppressed aldosterone (<6 ng/dL) excludes primary aldosteronism .
  • Validation : Compare with saline infusion and captopril tests. This compound’s specificity (94–98%) is superior in differentiating unilateral vs. bilateral adrenal hyperplasia .

Data Contradiction and Analysis

Q. How to address discrepancies in this compound’s efficacy across different shock models?

  • Methodological Answer :

  • Mechanistic Contextualization : In septic shock, this compound’s anti-inflammatory effects complement hydrocortisone’s glucocorticoid activity. In hemorrhagic/cardiogenic shock, limited efficacy may reflect divergent pathophysiology (e.g., non-corticoid-mediated vasodilation) .
  • Meta-Regression : Pool data from shock subtypes and assess effect modifiers (e.g., baseline fluid status, catecholamine use) using random-effects models .

Q. What explains variable hypertensive responses to this compound in rodent models?

  • Methodological Answer :

  • Genetic Stratification : Use Dahl salt-sensitive vs. resistant rats to isolate genetic susceptibility. This compound-induced hypertension is exacerbated in salt-sensitive strains due to ENaC dysregulation .
  • Dose-Response Curves : Establish thresholds for blood pressure elevation (e.g., >0.5 mg/kg/day in Sprague-Dawley rats) and correlate with renal MR receptor density via immunohistochemistry .

Tables

Table 1 : Key Clinical Trials Involving this compound

Study DesignPopulationInterventionPrimary Outcome (Risk Ratio)Reference
RCT (APROCCHSS)Septic shockHydrocortisone + this compound vs. placebo90-day mortality: RR 0.88 (95% CI 0.78–0.99)
Cross-over RCTOrthostatic hypotensionThis compound vs. midodrineSystolic BP improvement: 12 mmHg (p=0.03)
Retrospective cohortSubarachnoid hemorrhageThis compound vs. standard caremRS ≤2 at 90 days: OR 1.32 (95% CI 1.01–1.72)

Table 2 : Common Biomarkers in this compound Research

BiomarkerMeasurement MethodClinical/Preclinical Relevance
Plasma aldosteroneLC-MS/MSDiagnosing primary aldosteronism
Urinary Na+/K+ ratioIon-selective electrodeValidating mineralocorticoid activity
Salivary cortisolELISAAssessing HPA axis modulation

Retrosynthesis Analysis

AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.

One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.

Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.

Strategy Settings

Precursor scoring Relevance Heuristic
Min. plausibility 0.01
Model Template_relevance
Template Set Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis
Top-N result to add to graph 6

Feasible Synthetic Routes

Reactant of Route 1
Fludrocortisone
Reactant of Route 2
Fludrocortisone

Disclaimer and Information on In-Vitro Research Products

Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.